Literature DB >> 23042283

Is littoral cell angioma of the spleen as rare as previously believed in the pediatric population?

Ewa Matuszczak1, Joanna Reszec, Wojciech Dębek, Adam Hermanowicz, Lech Chyczewski.   

Abstract

Littoral cell angioma (LCA) is a rare primary splenic vascular tumor, originating from the littoral cells lining the red pulp sinuses of the spleen. There are only a handful of case reports of LCA in children to be found in the literature. We performed a retrospective analysis of the medical charts of pediatric patients with splenic lesions who were treated between 2005 and 2010 in the Pediatric Surgery Department of the Medical University of Bialystok. Surprisingly, LCA accounted for 37.5% of the splenic lesions found in our series. The majority of LCA tumors are benign, but given their malignant potential, splenectomy and long-term follow-up should be the gold standard for their management. We strongly support the use of further cross-sectional studies to properly elucidate the prevalence of littoral cell angioma of the spleen in the pediatric population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23042283     DOI: 10.5603/19761

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  4 in total

1.  Laparoscopic splenectomy for splenic littoral cell angioma.

Authors:  Yun-Qiang Cai; Xing Wang; Xun Ran; Xu-Bao Liu; Bing Peng
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

2.  A rare case of splenic littoral cell angioma in a child.

Authors:  Recep Bedir; Ibrahim Sehitoǧlu; Ahmet Salih Calapoǧlu; Cüneyt Yurdakul
Journal:  J Lab Physicians       Date:  2014-07

3.  Littoral Cell Angioma: A Rare Cause of Pediatric Thrombocytopenia.

Authors:  Mitul Jasani; Anirudh Shah; Amar Shah
Journal:  J Indian Assoc Pediatr Surg       Date:  2018 Jul-Sep

4.  Clinical Landscape of Littoral Cell Angioma in the Spleen Based on a Comprehensive Analysis.

Authors:  Weijie Wang; Guangzhao Qi; Xiangtian Zhao; Yanping Zhang; Rongtao Zhu; Ruopeng Liang; Yuling Sun
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.